Vasopressin and relativity: On the matter of deficiency and sensitivity

Critical Care Medicine

Volumn 34, Issue 4, 2006, Pages 1275-1277

  Landry, Donald W ^a   Oliver, Juan A ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Deficiency; Sensitivity; Shock; V1a receptor; Vasopressin

Indexed keywords

NITRIC OXIDE DONOR; NORADRENALIN; PHOSPHODIESTERASE INHIBITOR; VASOPRESSIN;

AUTONOMIC NEUROPATHY; BLEEDING; BRADYCARDIA; DRUG SAFETY; DRUG SENSITIVITY; EDITORIAL; ESOPHAGUS VARICES; FORWARD HEART FAILURE; HUMAN; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

ANIMALS; HUMANS; VASOPRESSINS;

EID: 33645827568     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000208105.76876.2E     Document Type: Editorial

References (15)

1. Oliver G, Schafer AE: On the physiological action of extracts of the pituitary body and certain other glandular organs. J Physiol 1895; 18:277-279
2. Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122-1125
3. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345:588-595
4. Leone M, Boyle WA: Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions. Crit Care Med 2006; 34:1126-1130
5. Wilson MF, Brackett DJ, Tompkins P, et al: Elevated plasma vasopressin concentrations during endotoxin and E. coli shock. Adv Shock Res 1981; 6:15-26
6. Holmes CL, Landry DW, Granton JT: Science review: Vasopressin and the cardiovascular system. Part 1: Receptor physiology. Crit Care 2003; 7:427-434
7. Edwards RM, Rizna W, Kinter LB: Renal microvascular effects of vasopressin and vasopressin antagonist. Am J Physiol 1989; 256:F274-F278
8. Aisenbrey GA, Handelman WA, Arnold P, et al: Vascular effects of arginine vasopressin during fluid deprivation in the rat. J Clin Invest 1981; 67:961-968
9. Graybiel A, Glendy RE: Circulatory effects following the intravenous administration of Pitressin in normal persons and in patients with hypertension and angina pectoris. Am Heart J 1941; 21:481-489
10. Padfield PL, Brown JJ, Lever AF, et al: Blood pressure in acute and chronic vasopressin excess. N Engl J Med 1981; 304:1067-1070
11. Wagner HN Jr, Braunwald E: The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension. J Clin Invest 1956; 35:1412-1418
12. Argenziano M, Choudhri AF, Oz MC, et al: A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 1997; 96(9 Suppl):II-286-II-290
13. Morales D, Madigan J, Cullinane S, et al: Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 1999; 100:226-229
14. Baker CH, Sutton ET, Zhou Z, et al: Microvascular vasopressin effects during endotoxin shock in the rat. Circ Shock 1990; 30:81-95
15. Holmes CL, Patel BM, Russell JA, et al: Physiology of vasopressin relevant to the management of septic shock. Chest 2001; 120:989-1002